X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (296) 296
index medicus (247) 247
overactive bladder (218) 218
urology & nephrology (193) 193
urinary bladder, overactive - drug therapy (172) 172
male (168) 168
urinary incontinence (157) 157
female (152) 152
efficacy (151) 151
muscarinic antagonists - therapeutic use (139) 139
extended-release (129) 129
tolterodine extended-release (123) 123
quality-of-life (120) 120
aged (119) 119
middle aged (118) 118
double-blind (110) 110
treatment outcome (104) 104
tolterodine (101) 101
tolerability (91) 91
quality of life (83) 83
adult (82) 82
extended-release tolterodine (76) 76
urology (75) 75
pharmacology & pharmacy (74) 74
oxybutynin (72) 72
urinary-tract symptoms (69) 69
benzhydryl compounds - therapeutic use (68) 68
muscarinic antagonists - adverse effects (64) 64
incontinence (63) 63
placebo-controlled trial (63) 63
tolterodine tartrate (62) 62
medicine, general & internal (60) 60
drug therapy (59) 59
medicine & public health (59) 59
aged, 80 and over (57) 57
care and treatment (57) 57
benign prostatic hyperplasia (55) 55
urinary incontinence - drug therapy (55) 55
urinary-incontinence (54) 54
double-blind method (50) 50
muscarinic antagonists - administration & dosage (50) 50
safety (50) 50
fesoterodine (49) 49
analysis (48) 48
cresols - therapeutic use (48) 48
symptoms (48) 48
phenylpropanolamine - therapeutic use (47) 47
antimuscarinic agent solifenacin (46) 46
bladder (46) 46
solifenacin (45) 45
trospium chloride (43) 43
solifenacin succinate (41) 41
detrusor overactivity (38) 38
antimuscarinics (37) 37
benzhydryl compounds - adverse effects (36) 36
cholinergic antagonists - therapeutic use (36) 36
urge incontinence (36) 36
head-to-head (35) 35
men (35) 35
benzhydryl compounds - administration & dosage (34) 34
randomized controlled-trial (34) 34
lower urinary tract symptoms (33) 33
prospective studies (32) 32
randomized controlled trials as topic (32) 32
surveys and questionnaires (32) 32
women (32) 32
drug therapy, combination (31) 31
obstetrics & gynecology (31) 31
clinical trials (30) 30
outlet obstruction (30) 30
young adult (30) 30
overactive bladder symptoms (29) 29
delayed-action preparations (28) 28
extended-release oxybutynin (28) 28
prevalence (28) 28
urinary bladder, overactive - physiopathology (28) 28
overactive bladder syndrome (27) 27
patient-reported outcomes (27) 27
selective receptor antagonist (27) 27
validation (27) 27
antimuscarinic (26) 26
internal medicine (26) 26
urinary bladder (26) 26
urinary bladder, overactive - complications (26) 26
drugs (25) 25
persistence (25) 25
tamsulosin (25) 25
adolescent (24) 24
health aspects (23) 23
impact (23) 23
mandelic acids - therapeutic use (23) 23
medical colleges (23) 23
open-label (23) 23
questionnaire (23) 23
adherence (22) 22
management (22) 22
cresols - adverse effects (21) 21
pharmacotherapy (21) 21
urgency (21) 21
urological agents - therapeutic use (21) 21
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
International Journal of Urology, ISSN 0919-8172, 10/2018, Volume 25, Issue 10, pp. 863 - 870
Journal Article
Neurourology and Urodynamics, ISSN 0733-2467, 11/2012, Volume 31, Issue 8, pp. 1258 - 1265
Aims To assess the efficacy and tolerability of fesoterodine 8 mg versus tolterodine extended release (ER) 4 mg in subjects with overactive bladder (OAB)... 
tolterodine | signs and symptoms | patient‐reported outcomes | fesoterodine | antimuscarinic agents | quality of life | randomized controlled trials | older persons | overactive bladder | patient-reported outcomes | DARIFENACIN | SAFETY | POPULATION-BASED SURVEY | TERMINOLOGY | RECEPTOR ANTAGONIST | CONTINENCE SOCIETY | INCONTINENCE | URINARY-TRACT SYMPTOMS | UROLOGY & NEPHROLOGY | HEAD-TO-HEAD | EXTENDED-RELEASE | Cresols - therapeutic use | Age Factors | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Cresols - adverse effects | Male | Muscarinic Antagonists - therapeutic use | Phenylpropanolamine - adverse effects | Phenylpropanolamine - therapeutic use | Young Adult | Urinary Bladder, Overactive - drug therapy | Benzhydryl Compounds - adverse effects | Urinary Bladder, Overactive - psychology | Time Factors | Urinary Bladder, Overactive - physiopathology | Tolterodine Tartrate | Urination - drug effects | Aged, 80 and over | Adult | Female | Surveys and Questionnaires | Urinary Incontinence, Urge - drug therapy | Urinary Incontinence, Urge - physiopathology | Benzhydryl Compounds - therapeutic use | Urinary Bladder, Overactive - diagnosis | Treatment Outcome | Urinary Incontinence, Urge - psychology | Randomized Controlled Trials as Topic | Urinary Incontinence, Urge - diagnosis | Adolescent | Quality of Life | Urinary Bladder - physiopathology | Urinary Bladder - drug effects | Aged
Journal Article
European Urology, ISSN 0302-2838, 2008, Volume 55, Issue 2, pp. 472 - 481
Journal Article